| Date | Form | Description | Docs | XBRL | Pages |
| 01/27/23 | DEF 14A | Definitive proxy statements |
|
17 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
27 | |
| 01/04/23 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
40 |
| 12/08/22 | 8-K | Current report filing |
|
|
5 |
| 11/01/22 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
Latest News & Events
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference
Read More...Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium
Read More...Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Read More...